Indoco Remedies Ltd Share Price

Overview

Indoco Remedies Ltd share price is currently ₹221.99, up by ₹5.40 (2.49%) from its previous closing price of ₹216.59. The share price has declined -9.99% over the past month and declined -23.12% over the past year. The stock's 52-week low and high are ₹160.31 and ₹330.36, respectively. Indoco Remedies Ltd has a market capitalisation of ₹ 2,090.00 Cr. The share price was last updated on 25 Aug 2026, 03:53 PM IST.

Indoco Remedies Ltd

INDOCO

₹0.00

₹5.40

2.49%

Healthcare

₹0.00(%)1D

Updated: 25 Aug 2026, 03:53:16 pm IST

Market Data

Open Price

₹217.07

Prev. Close

₹216.59

₹212.48

Day Low

₹225.71

Day High

₹160.31

52 Week Low

₹330.36

52 Week High

HealthcarePharmaceuticals & Drugs

CategorySmall Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

363.92

Sector PE

42.03

PB Ratio

2.20

Sector PB

5.83

EPS

0.61

Dividend Yield

0.12

Today's Volume

128.265 K

5 Day Avg. Volume

95.144 K

PEG Ratio

-12.57

Market Cap.

₹ 2,090.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Actions	Ex-Date	Record-Date
DividendsFinal Dividend of 10% at ₹0.2/Share	10-Sep-2026	10-Sep-2026
DividendsFinal Dividend of 10% at ₹0.2/Share	04-Sep-2025	04-Sep-2025
DividendsFinal Dividend of 75% at ₹1.5/Share	19-Sep-2024	20-Sep-2024

Mutual Fund Ownership

Mutual Fund Holder	Jun 26 Shares held	Jul 26 Shares held
Quant Small Cap Fund - Growth	41.99 Lac	41.99 Lac no change
DSP Healthcare Fund - Regular Plan - Growth	32.46 Lac	32.46 Lac no change
Nippon India Small Cap Fund - Growth	25.95 Lac	25.95 Lac no change
Nippon India Pharma Fund - Growth	18.35 Lac	18.35 Lac no change
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth	16.62 Lac	16.62 Lac no change

Show all holdings

About Indoco Remedies Ltd 👋

Indoco Remedies Limited is an India-based fully integrated, research-oriented pharmaceutical company. The Company is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The Company caters to both Domestic and International markets. Its products include SENSODENT-K, HOMIDE, DEXOREN-S, LORCHEK-MR, SENSOFORM, KIDODENT, NINAF, KARVOL PLUS, CYCLOPAM, LIGNOX+ADRENLINE, NOXA, CITAL-UTI, RENOLEN, REXIDIN-M, CITAL, SENSODENT-KF, CARMICIDE, TOBAREN-DM, FEBREX PLUS, SCABEX, CLOBEN-G, MOFLOREN-BF, OTOREX, ZINCOREN, SENOLIN, LIGNOX, HEMSYL, FEDRIS, REXIDIN, VEPAN, OXIPOD, TURBOCORT, MACUCHEK, and DENTOGEL. The Company has around 11 manufacturing facilities, seven for finished dosage forms (FDFs) and four for active pharmaceutical ingredients (APIs), supported by a research and development center and a clinical research organization facility.